Gender differences of left ventricular remodeling in patients with chronic heart failure
- Authors: Dadashova GM1
-
Affiliations:
- Scientific-Research Institute of Cardiology named after J. Abdullayev, Baku, Azerbaijan
- Issue: Vol 95, No 3 (2014)
- Pages: 362-366
- Section: Theoretical and clinical medicine
- URL: https://journals.rcsi.science/kazanmedj/article/view/1514
- DOI: https://doi.org/10.17816/KMJ1514
- ID: 1514
Cite item
Full Text
Abstract
Aim. To determine the gender differences in risk factors of left ventricular remodeling in patients with chronic heart failure associated with arterial hypertension and coronary heart disease. Methods. The study included 112 patients aged 45 to 60 years with myocardial scaring after myocardial infarction and functional class I-III of heart failure by NYHA. Patients were distributed to 2 groups: 1st included 60 males (mean age 54.8±3.3 years), 2nd - 52 females (mean age 55.8±3.1 years). To assess the cardiac function, all patients underwent echocardiography (B- and M-modes). Models of left ventricle architectonics were identified according to such parameters as left ventricle wall relative thickness index and left ventricular mass index. Results. Leading causes for heart failure in female patients were hypertension (50% of cases) and ischemic heart disease (23.1% of cases, 79.5% of ischemic heart disease cases were not associated). In males, ischemic heart disease was the leading reason for chronic heart failure (78.3% of cases, among them 80.9% with a history of survived myocardial infarction). In females, chronic heart failure was more often associated with isolated diastolic dysfunction (78.8% of cases versus 65% in males, p <0.05), and left ventricle ejection fraction was stable. Unfavorable types of left ventricle remodeling in terms of prognosis were more common among females, including eccentric left ventricle hypertrophy (67.3% of cases versus 53.3% in males, p <0.05) and concentric left ventricle hypertrophy (21% of cases versus 18.3% in males, p >0.05). Conclusion. There are gender differences in patients with chronic heart failure: prevalence of hypertension in women, and coronary heart disease in men; higher rate of isolated diastolic dysfunction prognostically unfavorable types of left ventricle remodeling (eccentric and concentric left ventricle hypertrophy) in females.
Full Text
##article.viewOnOriginalSite##About the authors
G M Dadashova
Scientific-Research Institute of Cardiology named after J. Abdullayev, Baku, Azerbaijan
Email: gulnazdadashova@mail.ru
References
- Беленков Ю.Н., Мареев В.Ю. Принципы рационального лечения сердечной недостаточности. - М.: Media Medica, 2000. - 266 с.
- Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Нейрогормоны и цитокины при сердечной недостаточности: новая теория старого заболевания? // Сердеч. недост. - 2000. - Т. 1, №4. - С. 135-138.
- Глезер М.Г., Сайгитов Р.Т. Эффективность лечения артериальной гипертонии индапамидом замедленного высвобождения у мужчин и женщин в зависимости от наличия сахарного диабета 2-го типа. Результаты программы БОЛЕРО // Пробл. жен. здоровья. - 2008. - Т. 3, №4. - С. 5-13.
- Ларина В.Н., Барт Б.Я., Головко М.Г. и др. Хроническая сердечная недостаточность у женщин и мужчин в пожилом возрасте: догоспитальный этап ведения // Пробл. жен. здоровья. - 2012. - Т. 7, №1. - С. 13-19.
- Cтаценко М.Е., Колодяжная О.И., Туркина С.В. и др. Гендерные особенности клинического течения и поражения сердца у пациентов с хронической сердечной недостаточностью зрелого пациента // Вестн. ВолгГМУ. - 2012. - Т. 3, №43. - С. 47-50.
- Терещенко С.Н., Жиров И.В. Гендерные различия при хронической сердечной недостаточности: миф или реальность. Сообщение 2. Патогенез и особенности фармакотерапии // Пробл. жен. здоровья. - 2007. - Т. 2, №1. - С. 69-74.
- Шальнова С.А., Деев А.Д., Константинов В.В. и др. Артериальная гипертония и оценка суммарного сердечно-сосудистого риска: результаты эпидемиологического мониторинга гипертонии // Consil. med. - 2007. - Т. 9, №11. - С. 31-34.
- Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространённость артериальной гипертонии в России: информированность, лечение, контроль // Профил. забол. и укрепл. здоровья. - 2001. - №2. - С. 3-7.
- Aronow W.S., Ahn C., Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease // Am. J. Cardiol. - 1990. - Vol. 66, N 17. - P. 1257-1259.
- Aurigemma G.P. Diastolic heart failure a common and lethal condition by any name // N. Engl. J. Med. - 2006. - Vol. 355, N 3. - P. 308-310.
- Bello N., Mosca L. Epidemiology of coronary heart disease in women // Prog. Cardiovasc. Dis. - 2004. - Vol. 46. - P. 287-295.
- Cleland J.G., Swedberg K., Follath F. et al. The Euroheart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis // Eur. Heart J. - 2003. - Vol. 24, N 5. - P. 442-463.
- Cowie Mr., Fox K.F., Wood D.A. et al. Hospitalization of patients with heart failure: a population-based study // Tur. Heart J. - 2002. - Vol. 23, N 11. - P. 877-885.
- Heidenreich P.A., Trogdon J.G., Khavjou O.A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association // Circulation. - 2011. - Vol. 123, N 8. - P. 933-944.
- Lloyd Jones D.M., Larson M.G., Leip E.P. et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study // Circulation. - 2002. - Vol. 106, N 24. - P. 3068-3072.
- Manolis A.J., Olympics C., Sifaki M. et al. Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure // Hypertension. - 1997. - Vol. 29, pt. 2. - P. 525-530.
